Renasant Corporation (RNST) — Fair Value Analysis

Base-case fair value (P50): $22.50 · Current price: $43.31 · Verdict: Overvalued

The Verdict on RNST

RENASANT CORP (RNST) is currently categorized as Deeply Overvalued based on our comprehensive Monte Carlo simulation analysis. Our rigorous valuation model, which simulates thousands of future scenarios across various economic and operational drivers, consistently indicates a median fair value (P50) of $22.50. This probabilistic assessment stands in stark contrast to RNST's current trading price of $43.31, which is significantly higher. The substantial -48.0% gap suggests that the market's current valuation of RNST materially exceeds the intrinsic fair value derived from our robust, scenario-driven simulations.

How RNST stacks up against peers

While RENASANT CORP's (RNST) operational and financial health quality tier is currently unrated, its present valuation trajectory against our fair value assessment is noteworthy. The Monte Carlo simulation's median fair value of $22.50 positions RNST considerably below its current trading level of $43.31. This implies a significant -48.0% downside based on our probabilistic models, irrespective of direct peer comparisons on operational metrics. For a company without a rated quality tier, this pronounced valuation disconnect between its current market price and its simulated intrinsic value warrants particular scrutiny from discerning investors.

What this means for investors

The FairCurve analysis clearly signals that RENASANT CORP (RNST) is trading at a premium relative to its probabilistically derived fair value. Investors considering RNST at its $43.31 should be keenly aware of the -48.0% difference between the current price and the median fair value of $22.50. While our models account for a range of potential outcomes, the statistical median suggests a considerable adjustment might be warranted in a downside scenario. For a comprehensive understanding of RNST's full bear and bull case distributions and to track its fair value as new fundamentals are released, sign up for a free FairCurve account.

Frequently Asked Questions

Is RNST overvalued or undervalued right now?

Based on Monte Carlo simulations, RENASANT CORP (RNST) is currently considered overvalued, with a median fair value (P50) of $22.50 significantly below its current price of $43.31.

What is the bear case and bull case for RNST?

Our full Monte Carlo distribution for RNST, including specific bear case (P10) and bull case (P90) targets, along with the probability of upside, is exclusively available to FairCurve account holders.

How does FairCurve calculate RNST's fair value?

FairCurve calculates RNST's fair value using sophisticated Monte Carlo simulations, modeling thousands of forward-looking scenarios to probabilistically derive its intrinsic value.

How can I track RNST's fair value as it changes?

You can easily track RNST's fair value by adding it to your free FairCurve watchlist, which provides daily updates and instant re-valuations whenever new fundamental data or earnings are released.